Keyphrases
Ovarian Cancer
100%
Epothilone B
100%
EpCAM Expression
100%
Epithelial Cell Adhesion Molecule (EpCAM)
40%
Ovarian Cancer Cells
30%
Taxol
30%
Tubulin Acetylation
30%
Vinblastine
20%
Discodermolide
20%
Flow Cytometry
10%
Biochemical Methods
10%
MRNA Expression
10%
Cell Surface
10%
Microtubules
10%
Metastatic Breast Cancer
10%
Immunofluorescence
10%
Taxanes
10%
Antibody Targeting
10%
Surrogate Marker
10%
Phase III Clinical Trial
10%
Stable Microtubules
10%
Surface Enhancement
10%
Microtubule Cytoskeleton
10%
Surface Antigen
10%
Nanomolar Concentrations
10%
Ixabepilone
10%
Epithelial Cell Adhesion
10%
Human Ovarian Cancer Cell
10%
Antigen Density
10%
Microtubule-Interacting Agents
10%
Microtubule Dynamic Instability
10%
Medicine and Dentistry
Ovarian Cancer
100%
Epothilone B
100%
Epithelial Cell Adhesion Molecule
100%
Microtubule
45%
Cancer Cell
27%
Acetylation
27%
Paclitaxel
27%
Discodermolide
18%
Tubulin
18%
Vinblastine
18%
Epithelial Cell
9%
Cell Surface
9%
Metastatic Breast Cancer
9%
Cytoskeleton
9%
Flow Cytometry
9%
Disease Marker
9%
Krukenberg Tumor
9%
Ovarian Cancer Cell Line
9%
Membrane Antigen
9%
Immunofluorescence Test
9%
Alpha Tubulin
9%
Clinical Trial
9%
Cell Adhesion
9%
Ixabepilone
9%
Messenger RNA
9%
Pharmacology, Toxicology and Pharmaceutical Science
Ovary Cancer
100%
Epothilone B
100%
Epithelial Cell Adhesion Molecule
100%
Paclitaxel
27%
Tubulin
18%
Vinblastine
18%
Discodermolide
18%
Ixabepilone
9%
Flow Cytometry
9%
Clinical Trial
9%
Metastatic Breast Cancer
9%
Disease Marker
9%
Ovary Carcinoma
9%
Membrane Antigen
9%
Alpha Tubulin
9%
Messenger RNA
9%
Taxane
9%